Overview

Tolperisone in Acute Muscle Spasm of the Back

Status:
Completed

Trial end date:
2019-07-12

Target enrollment:

Participant gender:

Summary

This is a double-blind, randomized, placebo-controlled, parallel group study of the efficacy and safety of tolperisone (a non-opioid) or placebo administered as multiple doses three times a day (TID) in approximately 400 male and female subjects experiencing back pain due to or associated with muscle spasm.

Phase:

Phase 2

Details

Lead Sponsor:

Neurana Pharmaceuticals, Inc.

Treatments:

Tolperisone